These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18193102)

  • 21. Dexlansoprazole for the treatment of esophagitis and GERD.
    Davies SL
    Drugs Today (Barc); 2010 Feb; 46(2):75-80. PubMed ID: 20393635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic management of gastroesophageal reflux disease.
    Ramakrishnan A; Katz PO
    Curr Gastroenterol Rep; 2002 Jun; 4(3):218-24. PubMed ID: 12010622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of ineffective esophageal motility with erosive and nonerosive gastroesophageal reflux disease.
    Foroutan M; Doust HM; Jodeiri B; Derakhshan F; Mohaghegh H; Mousapour H; Poursaadati S; Kiarudi MY; Zali M
    Indian J Gastroenterol; 2008; 27(2):58-61. PubMed ID: 18695304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of lansoprazole in children 13 to 24 months old with gastroesophageal reflux disease.
    Heyman MB; Zhang W; Huang B; Chiu YL; Amer F; Winter HS
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):35-40. PubMed ID: 17204950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview.
    Chiba N
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease.
    Isomoto H; Saenko VA; Kanazawa Y; Nishi Y; Ohtsuru A; Inoue K; Akazawa Y; Takeshima F; Omagari K; Miyazaki M; Mizuta Y; Murata I; Yamashita S; Kohno S
    Am J Gastroenterol; 2004 Apr; 99(4):589-97. PubMed ID: 15089887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
    Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
    Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New therapeutic options in the treatment of GERD and other acid-peptic disorders. Based on a presentation by Duane D. Webb, MD, FACG.
    Am J Manag Care; 2000 May; 6(9 Suppl):S467-75. PubMed ID: 10977486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
    Triadafilopoulos G; Kaczynska M; Iwane M
    Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children.
    Tolia V; Fitzgerald J; Hassall E; Huang B; Pilmer B; Kane R
    J Pediatr Gastroenterol Nutr; 2002; 35 Suppl 4():S300-7. PubMed ID: 12607790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori.
    Castro Fernández M; García Díaz E; Larraona JL; Rodríguez Hornillo MC; Lamas Rojas E; Núñez Hospital D; Pallarés Querol M
    Rev Esp Enferm Dig; 2006 Mar; 98(3):170-9. PubMed ID: 16737416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.
    Ashida K; Iwakiri K; Hiramatsu N; Sakurai Y; Hori T; Kudou K; Nishimura A; Umegaki E
    World J Gastroenterol; 2018 Apr; 24(14):1550-1561. PubMed ID: 29662293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopy versus endoscopic ultrasonography in staging reflux esophagitis.
    Caletti GC; Ferrari A; Mattioli S; Zannoli R; Di Simone MP; Bocus P; Gozzetti G; Barbara L
    Endoscopy; 1994 Nov; 26(9):794-7. PubMed ID: 7712992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease.
    Oberg S; Peters JH; DeMeester TR; Chandrasoma P; Hagen JA; Ireland AP; Ritter MP; Mason RJ; Crookes P; Bremner CG
    Ann Surg; 1997 Oct; 226(4):522-30; discussion 530-2. PubMed ID: 9351720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abdominal ultrasonography as a new modality for the diagnosis of gastroesophageal reflux disease.
    Tomita T; Iijima H; Kim Y; Oshima T; Hori K; Nishiguchi S; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S45-8. PubMed ID: 20586865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Caro JJ; Salas M; Ward A
    Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice.
    Cury EK; Schraibman V; Faintuch S
    J Pediatr Surg; 2004 Feb; 39(2):e4-7. PubMed ID: 14966764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.